| Product Name | Isavuconazole-d4 |
| Product Code | DA-I047-c |
| Chemical name | Isavuconazole-d4 |
| Synonyms | 4-[2-[(1R,2R)-2-(2,5-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile-d4; 2R,3R)-3-[4-(4-Cyanophenyl)thiazol-2-yl]-2-(2,5-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol-d4; BAL 4815-d4; RO 0094815-d4; |
| Impurity | NA |
| CAS Number | 1346598-58-0 |
| Alternate CAS # | NA |
| Molecular form | C22H13D4F2N5OS |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 441.49 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | aromatics,chiral standards,heterocycles,stable isotopes,pharmaceutical standards,intermediates,fine chemicals,sulphur and selenium compounds |
| Boiling Point | NA |
| Applications | Labelled Isavuconazole. It is a new triazole currently undergoing phase III clinical trials. This compound has shown in vitro activity against a large number of clinical important yeasts and molds including Aspergillus spp., Fusarium spp., Scedosporium spp., Candida spp., the Zygomycetes and Cryptococcus spp. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
